Recon Top Stories Onkos Surgical® expands access to NanoCept® Antibacterial Technology for patients requiring total femoral replacement byTim AllenSeptember 17, 2026
Regulatory Onkos Surgical® Receives FDA 510(k) Clearance for Application of NanoCept® Antibacterial Technology to Titanium Implants in the ELEOS™ Limb Salvage System byTim AllenJune 9, 2026
Recon Onkos Surgical® Announces Initiation of 522 Post-Market Surveillance Study of the ELEOS™ Limb Salvage System with NanoCept® Antibacterial Implant Technology byTim AllenFebruary 12, 2026
Recon Top Stories Onkos Surgical® Opens New Innovation Center for NanoCept® Antibacterial Technology byJosh SandbergDecember 10, 2025
Extremities Regulatory Onkos Surgical® Receives FDA 510(k) Clearance for ELEOS™ Proximal Tibia with NanoCept® Antibacterial Technology byJosh SandbergOctober 21, 2025
Recon Onkos Surgical® Successfully Completes Groundbreaking, First-in-Human Cases Using NanoCept™ Antibacterial Technology byTim AllenJanuary 9, 2025
Biologics Regulatory MCRA Supports Onkos Surgical with First FDA De Novo Approval for Antibacterial Coating for Implants byJosh SandbergJune 20, 2024
Recon Regulatory Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants byJosh SandbergApril 8, 2024
Biologics Regulatory Top Stories SINTX Announces New Antibacterial Biomedical Patents and Expansion of Intellectual Property Portfolio byJosh SandbergOctober 4, 2022
Biologics Scientists develop technology to produce bioactive coating with antibacterial effect byJosh SandbergMarch 31, 2016
